A detailed history of Klp Kapitalforvaltning As transactions in Biogen Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 191,677 shares of BIIB stock, worth $32.1 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
191,677
Previous 166,577 15.07%
Holding current value
$32.1 Million
Previous $23.3 Million 37.63%
% of portfolio
0.13%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 28, 2026

BUY
$142.26 - $167.55 $3.57 Million - $4.21 Million
25,100 Added 15.07%
191,677 $32.1 Million
Q2 2025

Jul 23, 2025

BUY
$113.38 - $135.49 $1.19 Million - $1.42 Million
10,500 Added 6.73%
166,577 $20.9 Million
Q1 2025

May 06, 2025

BUY
$133.43 - $153.27 $8.5 Million - $9.76 Million
63,700 Added 68.96%
156,077 $21.4 Million
Q4 2024

Feb 11, 2025

BUY
$146.47 - $191.55 $13.5 Million - $17.7 Million
92,377 New
92,377 $14.1 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $24.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Klp Kapitalforvaltning As Portfolio

Follow Klp Kapitalforvaltning As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klp Kapitalforvaltning As, based on Form 13F filings with the SEC.

News

Stay updated on Klp Kapitalforvaltning As with notifications on news.